Trinity Biotech plc Retained Earnings 2011-2025 | TRIB

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Trinity Biotech plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	10.6 M	16.2 M	55.3 M	47.8 M	91.3 M	-	-	-	171 M	154 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
171 M	10.6 M	78 M

Quarterly Retained Earnings Trinity Biotech plc

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	12.6 M	-	-	-	10.6 M	-	-	-	16.1 M	-	-	-	55.3 M	-	47.4 M	46.8 M	75.8 M	-	-	-	110 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
110 M	10.6 M	46.9 M

Retained Earnings of other stocks in the Diagnostics research industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-62.9 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	-280 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	-607 M	-	-61.36 %	$ 2.46 M	USA
Brainsway Ltd. BWAY	-77.3 M	$ 19.0	-1.91 %	$ 99.4 M	Israel
Burning Rock Biotech Limited BNR	-2.23 B	$ 20.67	-2.38 %	$ 222 M	China
Co-Diagnostics CODX	4.6 M	$ 0.23	-4.21 %	$ 6.75 M	USA
Biocept BIOC	-298 M	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	-200 M	$ 39.13	-0.67 %	$ 1.09 B	USA
Chembio Diagnostics CEMI	-154 M	-	0.22 %	$ 16.8 M	USA
Danaher Corporation DHR	44.2 B	$ 230.67	0.14 %	$ 169 B	USA
DarioHealth Corp. DRIO	-349 M	$ 10.56	5.18 %	$ 300 M	Israel
BioNano Genomics BNGO	-693 M	$ 1.5	-1.24 %	$ 1.91 M	USA
Exact Sciences Corporation EXAS	-4.5 B	$ 101.86	0.29 %	$ 18.9 B	USA
Oxford Immunotec Global PLC OXFD	-84 M	-	-	$ 562 M	Britain
DexCom DXCM	1.02 B	$ 67.82	0.36 %	$ 26.2 B	USA
Enzo Biochem ENZ	-294 M	-	-8.98 %	$ 14.8 K	USA
Fulgent Genetics FLGT	590 M	$ 26.63	-0.34 %	$ 805 M	USA
Global Cord Blood Corporation CO	2.89 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-624 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-150 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-4.94 B	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-424 M	-	-11.32 %	$ 2.94 M	USA
PRA Health Sciences, Inc. PRAH	440 M	-	-	$ 10.7 B	USA
CareDx, Inc CDNA	-678 M	$ 19.07	-2.13 %	$ 1.03 B	USA
Celcuity CELC	-272 M	$ 101.03	-1.19 %	$ 3.99 B	USA
Heska Corporation HSKA	-169 M	-	-	$ 1.31 B	USA
Anixa Biosciences ANIX	-241 M	$ 3.18	-0.49 %	$ 101 K	USA
HTG Molecular Diagnostics HTGM	-230 M	-	-20.0 %	$ 1.06 M	USA
IQVIA Holdings IQV	6.06 B	$ 226.77	-0.06 %	$ 41.1 B	USA
Guardant Health GH	-2.58 B	$ 101.71	-1.23 %	$ 12.5 B	USA
Aspira Women's Health AWH	-499 M	-	-6.19 %	$ 10.5 M	USA
Neogen Corporation NEOG	-536 M	$ 7.22	1.26 %	$ 1.57 B	USA
Myriad Genetics MYGN	-757 M	$ 6.34	-2.24 %	$ 574 M	USA
ENDRA Life Sciences NDRA	-103 M	$ 4.84	-4.72 %	$ 2.6 M	USA
National Research Corporation NRC	-30.5 M	$ 18.99	1.74 %	$ 466 M	USA
Illumina ILMN	-1.24 B	$ 134.1	-0.63 %	$ 21.3 B	USA
Charles River Laboratories International CRL	1.81 B	$ 202.95	-0.29 %	$ 10.4 B	USA
Personalis PSNL	-550 M	$ 8.04	-1.29 %	$ 476 M	USA
Quidel Corporation QDEL	945 M	$ 29.17	-0.44 %	$ 1.23 B	USA
Quest Diagnostics Incorporated DGX	9.36 B	$ 175.53	-0.24 %	$ 19.5 B	USA
Biodesix BDSX	-462 M	$ 6.84	0.22 %	$ 887 M	USA
RadNet RDNT	-76.8 M	$ 73.13	-0.03 %	$ 5.34 B	USA
Motus GI Holdings MOTS	-154 M	-	-34.28 %	$ 263 K	Israel
Laboratory Corporation of America Holdings LH	8.3 B	$ 253.05	-0.36 %	$ 21.2 B	USA
ICON Public Limited Company ICLR	2.72 B	$ 182.3	-0.29 %	$ 15 B	Irlanda
IDEXX Laboratories IDXX	5.33 B	$ 684.48	-0.58 %	$ 56.4 B	USA
Lantheus Holdings LNTH	446 M	$ 66.89	0.27 %	$ 4.63 B	USA
Mettler-Toledo International MTD	8.37 B	$ 1 414.37	-0.42 %	$ 30 B	Schweiz
Agilent Technologies A	348 M	$ 137.94	-0.33 %	$ 41.9 B	USA